Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease
DHM can significantly ameliorate salivation in PD patients over 24 weeks, with fewer adverse effects.
Authors
- Yichao Zhu (ORCID: https://orcid.org/0000-0001-8150-7353)
- Ting Huang (ORCID: https://orcid.org/0000-0001-7540-274X)
- Jing Wu (ORCID: https://orcid.org/0000-0002-9017-8405)
- Qing Gao (ORCID: https://orcid.org/0009-0000-9854-9250)
- You‐Yong Tian
- Huihui Jin
Institutions
- Nanyang Institute of Technology (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Clinical Neurology and Neurosurgery
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1016/j.clineuro.2025.109239
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39